Author

M. K. Nyati

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

A. Ahsan· 1 shared A. Pal· 1 shared A. Rehemtulla· 1 shared D. Markovitz· 1 shared D. Ray· 1 shared D. Thomas· 1 shared K. Raghunathan· 1 shared M. Legendre· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Ahsan

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A molecularly engineered lectin destroys EGFR and inhibits the growth of non-small cell lung cancer

S. M. Chan, Z. Raglow, A. Pal, S. D. Gitlin, M. Legendre, D. Thomas, R. K. Mehta, M. Tan, M. K. Nyati, A. Rehemtulla, D. Markovitz

This paper demonstrates that the engineered lectin H84T binds to and inhibits NSCLC cell growth by lysosomal degradation of EGFR, independent of EGFR mutation status.

bioRxiv · Mar 18, 2024 · PreprintCancer Biology

Mutant EGFR is a preferred SMURF2 substrate of ubiquitination: role in enhanced receptor stability and TKI sensitivity

P. Ray, K. Raghunathan, A. Ahsan, U. S. Allam, S. Shukla, V. Basrur, S. Veatch, T. S. Lawrence, M. K. Nyati, D. Ray

This paper identifies SMURF2-mediated ubiquitination of EGFR mutants as a mechanism enhancing receptor stability and TKI sensitivity.

bioRxiv · Apr 2, 2020 · PreprintCancer Biology